CLINICAL_TRIALS
trial_result
· 2013-10-22
Clinical Trial Update: Kaletra Sex/Gender Pharmacokinetics (PK) Study [Phase 4]
Summary
Phase 4 pharmacokinetic study evaluating sex/gender differences in Kaletra (lopinavir/ritonavir) for HIV infection; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2013-10-22